Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Filipin III (SKU B6034): Reliable Cholesterol Detection f...
2026-01-15
This article addresses key laboratory challenges in cholesterol detection using Filipin III (SKU B6034), a polyene macrolide antibiotic optimized for membrane cholesterol visualization. Through scenario-driven Q&A, it demonstrates best practices, protocol optimization, and vendor selection strategies to ensure reproducibility and data integrity in cell-based assays.
-
Bortezomib (PS-341): Reversible Proteasome Inhibitor for ...
2026-01-14
Bortezomib (PS-341) is a potent, reversible proteasome inhibitor used in cancer research and therapy. It exhibits nanomolar antiproliferative activity in multiple cell lines and is clinically approved for relapsed multiple myeloma and mantle cell lymphoma. This article provides mechanistic, benchmarked, and workflow-relevant insights for researchers utilizing Bortezomib in proteasome-regulated cellular process studies.
-
MG-132 (SKU A2585): Practical Solutions for Apoptosis and...
2026-01-14
This article delivers actionable, scenario-driven guidance for researchers using MG-132 (SKU A2585) in viability, apoptosis, and cell cycle assays. Drawing on quantitative benchmarks, literature, and recent findings, it demonstrates how APExBIO’s MG-132 provides reproducible, high-sensitivity results while addressing common laboratory pain points in workflow optimization and data interpretation.
-
MG-132: Precision Proteasome Inhibitor for Apoptosis and ...
2026-01-13
MG-132, a potent cell-permeable proteasome inhibitor peptide aldehyde, empowers researchers to unravel the complex pathways of apoptosis, cell cycle arrest, and protein degradation in cancer models. This comprehensive guide details experimental workflows, troubleshooting strategies, and novel applications, making it an essential resource for effective ubiquitin-proteasome system inhibition.
-
Bortezomib (PS-341): Benchmark Reversible Proteasome Inhi...
2026-01-13
Bortezomib (PS-341) is a gold-standard reversible proteasome inhibitor for cancer therapy research. Its nanomolar potency, validated apoptosis induction, and robust performance in multiple myeloma and mantle cell lymphoma models make it essential for dissecting proteasome-regulated cellular processes. APExBIO’s A2614 product delivers reproducible inhibition and workflow flexibility.
-
Filipin III (SKU B6034): Reliable Cholesterol Detection i...
2026-01-12
This article provides a scenario-driven, data-backed guide to using Filipin III (SKU B6034) for robust cholesterol detection in cell biology and metabolic disease research. Drawing on recent literature and practical lab experience, it addresses key workflow challenges, experimental optimization, and vendor selection, helping researchers achieve reproducible and sensitive results with APExBIO Filipin III.
-
MG-132 Proteasome Inhibitor: Precision Tools for Apoptosi...
2026-01-12
MG-132 (Z-LLL-al) from APExBIO is a gold-standard, cell-permeable proteasome inhibitor peptide aldehyde enabling researchers to dissect the ubiquitin-proteasome system with exceptional specificity. This article delivers actionable workflows, advanced troubleshooting, and comparative insights to empower apoptosis, cell cycle regulation, and cancer research applications.
-
Filipin III: A Precision Tool for Cholesterol Microdomain...
2026-01-11
Explore how Filipin III, a polyene macrolide antibiotic, enables ultrastructural membrane cholesterol visualization and advances our understanding of cholesterol-driven disease mechanisms. Discover distinct insights into cholesterol-rich microdomains, membrane biology, and the latest applications in metabolic dysfunction research.
-
Filipin III (SKU B6034): Precision Cholesterol Detection ...
2026-01-10
This article addresses common laboratory challenges in membrane cholesterol detection and highlights how Filipin III (SKU B6034) enables reproducible, high-sensitivity assays in cell viability and membrane studies. Scenario-driven Q&A blocks offer practical advice for experimental design, troubleshooting, and vendor selection—anchored by literature-backed insights and direct application of Filipin III from APExBIO.
-
Filipin III: Benchmark Cholesterol-Binding Probe for Memb...
2026-01-09
Filipin III is a polyene macrolide antibiotic and gold-standard cholesterol-binding fluorescent probe for visualizing membrane cholesterol distribution. Its high specificity, defined mechanism, and reproducible performance make it indispensable for advanced membrane research. APExBIO’s Filipin III (SKU B6034) provides robust detection of cholesterol-rich microdomains, supporting lipid raft and metabolic disorder studies.
-
MG-132: Benchmark Proteasome Inhibitor for Apoptosis and ...
2026-01-09
MG-132 is a potent, cell-permeable proteasome inhibitor peptide aldehyde widely used in apoptosis research and cell cycle arrest studies. This article provides atomic, verifiable facts on its mechanism, benchmarks, and optimal workflow integration. MG-132 remains a reference compound for dissecting the ubiquitin-proteasome system and oxidative stress responses in cancer and proteostasis research.
-
Bortezomib (PS-341): Reversible Proteasome Inhibitor for ...
2026-01-08
Bortezomib (PS-341) from APExBIO empowers researchers to dissect proteasome-regulated cellular processes and apoptosis with precision, offering reliable potency in both cancer therapy studies and mechanistic cellular assays. Its unique reversibility and robust performance across diverse model systems set it apart for advanced workflow integration and troubleshooting.
-
Filipin III: Gold-Standard Cholesterol Detection in Membr...
2026-01-07
Filipin III, a polyene macrolide antibiotic, delivers unmatched specificity and sensitivity for cholesterol detection in biological membranes. APExBIO’s Filipin III streamlines workflows for advanced membrane cholesterol visualization, enabling breakthroughs in lipid raft, MASLD, and disease mechanism research.
-
MG-132: Proteasome Inhibition as a Precision Tool for Dis...
2026-01-06
Explore how MG-132, a cell-permeable proteasome inhibitor peptide aldehyde, is redefining research on protein homeostasis, apoptosis, and cell cycle arrest. Discover unique insights into proteostasis, ER stress, and advanced disease modeling that set this article apart from existing resources.
-
MG-132: Unraveling Proteasome Inhibition for Apoptosis an...
2026-01-05
Discover the multifaceted role of MG-132, a potent proteasome inhibitor peptide aldehyde, in apoptosis assay development and cancer research. This article offers an advanced, mechanistic analysis of MG-132’s impact on ubiquitin-proteasome system inhibition and oxidative stress, presenting unique insights beyond standard protocols.
16689 records 17/1113 page Previous Next First page 上5页 1617181920 下5页 Last page